Reinhold Schulz joins Flourish Research as Chief Executive Officer. Schulz is a seasoned pharmaceutical services executive with decades of industry experience.
NEW YORK, Aug. 15, 2022 /PRNewswire-PRWeb/ -- Reinhold Schulz has been named Chief Executive Officer of Flourish Research, a company designed to acquire, operate, and integrate the best clinical research sites in North America. Flourish operates large, best-in-class sites with experience in Phases I-IV and investigators with deep expertise in key therapeutic areas.
Schulz will lead operations and integration of the rapidly growing organization to ensure Flourish continues to deliver high-quality results for its sponsor/CRO partners, while providing patients with an exceptional clinical experience. As a seasoned pharmaceutical services executive with decades of industry experience, Schulz most recently led PPD's Global Site Network at Accelerated Enrollment Solutions, with oversight of more than 160 clinical research sites and 1,300 employees in 15 countries.
Prior to Accelerated Enrollment Solutions, Reinhold served as Head of Early Phase Development clinical research sites at PPD. Before joining PPD, he spent 17 years at PAREXEL in various roles supporting the company's clinical research site strategy.
"I'm excited for the opportunity to drive the continued growth and integration of already best-in-class sites," said Schulz. "Flourish is at the forefront of an evolving industry, where site consolidation offers the benefits of systematic clinical procedures, a broader patient database, and a deeper network of knowledge. These benefits offer higher quality services for sponsor/CROs and patients."
Schulz holds a Bachelor of Science in Chemistry, Biochemistry and Physiology and a Bachelor of Medical Science in Pharmacology from the University of Free State, Bloemfontein South Africa. He also holds a Master of Business Administration from the University of Phoenix.
About Flourish Research:
Flourish Research is a leading clinical trial organization, created to strategically acquire, integrate, and operate the best clinical trial sites in North America. Flourish sites started as some of the most recognized trial sites in the industry including Clinical Trials of Texas, Excel Medical Clinical Trials, Clinical Site Partners and Great Lakes Clinical Trials.
Flourish sites conduct Phase I-IV studies across therapeutic areas where they have deep expertise, including Cardiology/Metabolic Disease/Renal, CNS, Pulmonology and Vaccines. Flourish key investigators are full-time, dedicated to research at sites that are large and highly experienced.
Cindi Heckmann, Flourish Research, 1 (210) 854-1614, [email protected]
SOURCE Flourish Research